The Mount Sinai Hospital’s Cardiac Catheterization Lab Awarded Highest Safety Rating in New York State
Three cardiologists also receive distinguished “two-star” ratings for percutaneous coronary interventions; 21st straight year of honors
The Cardiac Catheterization Laboratory of Mount Sinai Heart at The Mount Sinai Hospital has received the highest "two-star" safety rating from the New York State Department of Health for percutaneous coronary intervention (PCI), overall and in non-emergency cases. This marks the 21st consecutive year that the Mount Sinai Catheterization Laboratory or its physicians have been awarded the prestigious designation for safety rates significantly exceeding the statewide average. Only three hospitals in the state have this ranking for PCI.
Samin Sharma, MD, Director of Clinical and Interventional Cardiology at The Mount Sinai Hospital; Annapoorna Kini, MD, Director of the Cardiac Catheterization Laboratory at The Mount Sinai Hospital; and Pedro Moreno, Professor of Cardiology at the Icahn School of Medicine at Mount Sinai have also received “two-star” safety ratings for PCI. The new report shows they performed a combined 6,529 cases, and that Mount Sinai has the most interventional cardiologists in the state with “two-star” ratings.
“Patient safety is our top priority at The Mount Sinai Hospital Cath Lab. Our efficiency and safety outcomes are unparalleled, and we are very proud of this achievement which is only possible because of the talented and dedicated interventional cardiology team,” says leading interventional cardiologist Dr. Sharma.
PCI, also known as angioplasty, is a minimally invasive procedure performed inside a catheterization laboratory. It is used to diagnose and treat patients with heart disease or blocked heart arteries. A thin catheter is threaded through the body, typically from an artery in the groin, to a blocked vessel in the heart. A diagnosed blockage can be removed, often with a stent that is inserted to restore blood flow within the vessel. Patients entering a cardiac catheterization laboratory can range from non-emergency cases experiencing early heart disease symptoms up to emergency cases who are suffering a myocardial infarction or heart attack.
The new data released by the Department of Health reports on the outcomes of patients who were discharged from all 61 statewide cardiac catheterization labs from December 1, 2013, to November 30, 2016. The “Percutaneous Coronary Interventions (PCI) in New York State 2014-2016” report tracked PCI data in overall, non-emergency, and emergency cases.
During this three-year period, Mount Sinai's Cardiac Catheterization Laboratory achieved significantly higher safety and survival rates than the statewide average, even while performing the highest number of PCI procedures in New York (10,888). Mount Sinai's risk-adjusted mortality rate, or RAMR, for all cases (0.90 percent) was significantly lower than the statewide average (1.18 percent). Also, the RAMR mortality rate for non-emergency cases (0.58 percent) was significantly lower than the statewide average (.77 percent).
Of the 10 centers with the highest volume in New York State, Mount Sinai was the only one to have an overall RAMR significantly lower than the statewide rate for non-emergency cases.
“Our procedural outcomes data over the last several years support the statement that we have mastered the art of PCI. As a result, many patients who were considered too high-risk to receive care elsewhere are referred here. As we increasingly accept complex cases, our PCI complications continue to decline, which is a testament to the quality work this Cath Lab achieves," says Dr. Kini.
“I believe the Mount Sinai Cath Lab remains the top center for PCI for a few reasons. Primarily, we have an extremely talented group of interventionalists and supporting staff. Secondly, we strictly abide by protocols and standards of care, while embracing new technologies, techniques and innovations, and lastly, the compassion and genuine concern for our patients’ health is the top priority for this lab,” says Dr. Moreno.
For more information on The Cardiac Catheterization Laboratory of Mount Sinai Heart at The Mount Sinai Hospital visit this link: https://www.mountsinai.org/locations/interventional-cardiology-cath-lab
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across eight hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2024-2025.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.